Nereus Pharmaceuticals
From Wikipedia, the free encyclopedia
Company typePrivate
IndustryPharmaceuticals
FoundedSan Diego, California, United States (1988)
FounderMichael A. Palladino, Kobi M. Sethna, Stan Fleming, William Fenical
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | San Diego, California, United States (1988) |
| Founder | Michael A. Palladino, Kobi M. Sethna, Stan Fleming, William Fenical |
| Headquarters | San Diego, California, United States |
Key people | Michael A. Palladino Ph.D.(Scientific Co-founder, SVP and Chief Technology Officer) Kobi M. Sethna (President, CEO)[1] Gary Shearman (Chairman of the Board)[2] G. |
Number of employees | 36[3] |
| Website | www.nereuspharm.com |
Nereus Pharmaceuticals was a pharmaceutical company focused on the development of natural products from marine microbial and other natural sources into small molecule human therapeutics.[4] The major disease area addressed by Nereus is cancer. Nereus was purchased by Triphase Research and Development in 2012.[5]